Sutter Visiting Nurse Association And Hospice Medicare Approved Location: 3001 Lava Ridge Court, Suite 330b, Roseville, California 95661 Phone: (916) 797-7850 |
Bristol Hospice - Sacramento, Llc Medicare Approved Location: 2140 Professional Drive, Suite 210, Roseville, California 95661 Phone: (916) 782-5511 |
Green Valley Hospice, Inc Medicare Approved Location: 3009 Douglas Blvd, Suite 160, Roseville, California 95661 Phone: (916) 757-6800 |
News Archive
Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis (UC), including isolated proctitis.
An interdisciplinary research team led by The University of Texas Medical Branch at Galveston reports a new breakthrough in countering the deadly effects of radiation exposure. A single injection of a regenerative peptide was shown to significantly increase survival in mice when given 24 hours after nuclear radiation exposure.
An infant's scores on the so-called Apgar scale can predict the risk of a later diagnosis of cerebral palsy or epilepsy. The risk rises with decreasing Apgar score, but even slightly lowered scores can be linked to a higher risk of these diagnoses, according to an extensive observational study by researchers at Karolinska Institutet in Sweden published in the esteemed journal The BMJ.
Parents of school-aged children in every public and nonpublic school throughout Missouri will be able to receive instant updates about the H1N1 (Swine) flu as a result of a new, free service provided by the Missouri School Boards' Association in collaboration with SchoolReach, a St. Louis-based school-to-parent notification and communications company. The service is available now to schools that do not already have an alert notification in place for parents.
The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise important safety information that women and their health care professionals need to have when considering use of the drug.
› Verified 1 days ago